Veterinary Medicines

Quiflor 20 mg/ml solution for injection for cattle, pigs and dogs

Not authorised
  • Marbofloxacin
Download as PDF

Product identification

Medicine name:
Quiflor 20 mg/ml solution for injection for cattle, pigs and dogs
Quiflor 20 mg/ml soluzione iniettabile per bovini, suini e cani
Active substance:
  • Marbofloxacin
Target species:
  • Cattle (pre-ruminant)
  • Dog
  • Pig
Route of administration:
  • Intravenous use
  • Subcutaneous use
  • Intramuscular use

Product details

Active substance and strength:
  • Marbofloxacin
    20.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intravenous use
    • Cattle (pre-ruminant)
      • Meat and offal
        6
        day
  • Subcutaneous use
    • Cattle (pre-ruminant)
      • Meat and offal
        6
        day
  • Intramuscular use
    • Cattle (pre-ruminant)
      • Meat and offal
        6
        day
    • Pig
      • Meat and offal
        4
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01MA93
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Surrendered
Authorised in:
  • Italy
Package description:
  • (ID4): 1 unspecified outer container with 1 Vial (Glass) with 20 millilitre(s) (20 millilitre(s))
  • (ID3): 1 unspecified outer container with 1 Vial (Glass) with 250 millilitre(s) (250 millilitre(s))
  • (ID2): 1 unspecified outer container with 1 Vial (Glass) with 100 millilitre(s) (100 millilitre(s))
  • (ID1): 1 unspecified outer container with 1 Vial (Glass) with 50 millilitre(s) (50 millilitre(s))

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • KRKA tovarna zdravil d.d. Novo mesto
Marketing authorisation date:
Manufacturing sites for batch release:
  • KRKA tovarna zdravil d.d. Novo mesto
  • TAD Pharma GmbH
Responsible authority:
  • Ministry Of Health
Authorisation number:
  • 104299
Date of authorisation status change:
Reference member state:
  • Germany
Procedure number:
  • DE/V/0301/001

Documents

Summary of Product Characteristics

English (PDF)
Published on: 14/02/2022
Download

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Italian (PDF)
Published on: 5/04/2022
Download